[CSF biomarkers in children with acute encephalopathy syndrome]

Naoyuki Tanuma1

  • 1Department of Pediatrics, Tokyo Metropolitan Fuchu Medical Center for the Disabled.

Insights

Viral infection-associated acute encephalopathy, a severe condition in children, presents with impaired consciousness and seizures. Tau protein and 8-hydroxy-2'deoxyguanosine (8-OHdG) show potential as biomarkers for early diagnosis and treatment monitoring.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Biomarker Discovery

Context:

  • Acute encephalopathy in children, often triggered by viral infections, carries significant mortality and neurological risks.
  • Key symptoms include impaired consciousness, status epilepticus, and hyperpyrexia.
  • Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is a specific subtype with characteristic biphasic seizures and MRI findings.

Purpose:

  • To identify potential biomarkers for the early diagnosis and management of viral infection-associated acute encephalopathy.
  • To differentiate AESD from febrile seizures in the early clinical phase.
  • To explore the utility of tau protein and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in monitoring disease progression and therapeutic response.

Summary:

  • Viral infection-associated acute encephalopathy is a critical pediatric neurological syndrome.
  • AESD presents with biphasic seizures and specific MRI abnormalities, posing diagnostic challenges.
  • Tau protein and 8-OHdG are proposed as promising biomarkers for early detection and treatment monitoring.

Impact:

  • Early diagnosis of AESD can lead to timely intervention, potentially mitigating severe neurological impairment.
  • Identifying reliable biomarkers like tau protein and 8-OHdG could revolutionize the management of acute encephalopathy.
  • Improved monitoring of treatment efficacy through biomarkers may enhance patient outcomes and reduce long-term sequelae.

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...